Status:
ENROLLING_BY_INVITATION
Mayo Clinic Phage Program Biobank
Lead Sponsor:
Mayo Clinic
Conditions:
Bacteriophage Therapy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to help scientists and clinicians discover answers to research questions related to antibiotic-resistant bacterial infections, and the role that phage therapy plays as a p...
Eligibility Criteria
Inclusion
- ≥ 18 years of age.
- Able to provide informed consent.
- Individual must have a future treatment plan to receive or has historically received phage therapy.
Exclusion
- Individuals , 18 years of age.
- Unwilling/unable to provide informed consent.
Key Trial Info
Start Date :
April 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05314426
Start Date
April 19 2022
End Date
April 1 2027
Last Update
June 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905